series-a
Stage
2017
Founded
4
Investors
About
Elasmogen is a biopharmaceutical company developing next-generation soloMER™ biologics. We specialize in high-affinity, site-specific treatments for solid-tumor cancers and inflammatory diseases.
Explore Elasmogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.